Analystreport

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating.

AMAG PHARMACEUTICALS  (AMAG) 
Last amag pharmaceuticals earnings: 3/4 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: amagpharma.com/investors